Literature DB >> 22538344

The influence of extracellular and intracellular calcium on the secretion of renin.

Douglas K Atchison1, William H Beierwaltes.   

Abstract

Changes in plasma, extracellular, and intracellular calcium can affect renin secretion from the renal juxtaglomerular (JG) cells. Elevated intracellular calcium directly inhibits renin release from JG cells by decreasing the dominant second messenger intracellular cyclic adenosine monophosphate (cAMP) via actions on calcium-inhibitable adenylyl cyclases and calcium-activated phosphodiesterases. Increased extracellular calcium also directly inhibits renin release by stimulating the calcium-sensing receptor (CaSR) on JG cells, resulting in parallel changes in the intracellular environment and decreasing intracellular cAMP. In vivo, acutely elevated plasma calcium inhibits plasma renin activity (PRA) via parathyroid hormone-mediated elevations in renal cortical interstitial calcium that stimulate the JG cell CaSR. However, chronically elevated plasma calcium or CaSR activation may actually stimulate PRA. This elevation in PRA may be a compensatory mechanism resulting from calcium-mediated polyuria. Thus, changing the extracellular calcium in vitro or in vivo results in inversely related acute changes in cAMP, and therefore renin release, but chronic changes in calcium may result in more complex interactions dependent upon the duration of changes and the integration of the body's response to these changes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538344      PMCID: PMC3553253          DOI: 10.1007/s00424-012-1107-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  125 in total

1.  PLASMA RENIN ACTIVITY IN ACUTE TUBULAR NECROSIS AND OTHER RENAL DISEASES ASSOCIATED WITH HYPERTENSION.

Authors:  W H TU
Journal:  Circulation       Date:  1965-05       Impact factor: 29.690

2.  Acquired bartter-like syndrome associated with gentamicin administration.

Authors:  Chu-Lin Chou; Yeong-Hwang Chen; Tom Chau; Shih-Hua Lin
Journal:  Am J Med Sci       Date:  2005-03       Impact factor: 2.378

3.  Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways.

Authors:  Susan K Fellner; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-14

4.  Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.

Authors:  G Bernini; A Moretti; S Lonzi; C Bendinelli; P Miccoli; A Salvetti
Journal:  Metabolism       Date:  1999-03       Impact factor: 8.694

5.  Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.

Authors:  U Russ; U Rauch; U Quast
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

6.  Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor.

Authors:  Donald T Ward; David Maldonado-Pérez; Laura Hollins; Daniela Riccardi
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

7.  Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3.

Authors:  A Kurtz; K H Götz; M Hamann; C Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism.

Authors:  L Kovács; M I Góth; I Szabolcs; O Dohán; A Ferencz; G Szilágyi
Journal:  Eur J Endocrinol       Date:  1998-05       Impact factor: 6.664

9.  Role of cGMP-kinase II in the control of renin secretion and renin expression.

Authors:  C Wagner; A Pfeifer; P Ruth; F Hofmann; A Kurtz
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells.

Authors:  S Gambaryan; C Wagner; A Smolenski; U Walter; W Poller; W Haase; A Kurtz; S M Lohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  23 in total

Review 1.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.

Authors:  Silvana Bazúa-Valenti; Lorena Rojas-Vega; María Castañeda-Bueno; Jonatan Barrera-Chimal; Rocío Bautista; Luz G Cervantes-Pérez; Norma Vázquez; Consuelo Plata; Adrián R Murillo-de-Ozores; Lorenza González-Mariscal; David H Ellison; Daniela Riccardi; Norma A Bobadilla; Gerardo Gamba
Journal:  J Am Soc Nephrol       Date:  2018-05-30       Impact factor: 10.121

Review 3.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

4.  Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway.

Authors:  M Cecilia Ortiz-Capisano; Douglas K Atchison; Pamela Harding; Robert D Lasley; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-24

Review 5.  Is the renin-angiotensin system actually hypertensive?

Authors:  Etienne Bérard; Olivier Niel; Amandine Rubio
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

6.  Analysis of the calcium paradox of renin secretion.

Authors:  D Steppan; L Pan; K W Gross; A Kurtz
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-27

7.  Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.

Authors:  M Cecilia Ortiz-Capisano; Mahendranath Reddy; Mariela Mendez; Jeffrey L Garvin; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

8.  Clinical Impact of p27Kip1 and CaSR Expression on Primary Hyperparathyroidism.

Authors:  Gozde Sengul Aycicek; Berna Imge Aydogan; Mustafa Sahin; Cevriye Cansız Ersoz; Serpil Dizbay Sak; Nilgun Baskal
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

Review 9.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

Review 10.  Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.

Authors:  Jenifer M Brown; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.